🇯🇵 Ajovy in Japan

PMDA authorised Ajovy on 23 June 2021

Marketing authorisation

PMDA — authorised 23 June 2021

  • Marketing authorisation holder: OTSUKA PHARMACEUTICAL Co., Ltd.
  • Status: approved

Ajovy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Ajovy approved in Japan?

Yes. PMDA authorised it on 23 June 2021.

Who is the marketing authorisation holder for Ajovy in Japan?

OTSUKA PHARMACEUTICAL Co., Ltd. holds the Japanese marketing authorisation.